Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Hair disorder, Immunisation, Off label use, SARS-CoV-2 test
Clinical narrative: Caller's hair gradually become more and more curly, "hair changing" after the vaccination.; Dose: 3rd; Date: 16Oct2021; off label use; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team from a Pfizer Sponsored Program. The reporter is the patient.  A 85 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm, administration date 16Oct2021 (Lot number: FE3590) at the age of 84 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Cholesterol" (unspecified if ongoing); "Blood pressure" (unspecified if ongoing); "T & A", start date: 1941 (unspecified if ongoing); "Miscarriage", start date: 1959 (unspecified if ongoing); "D&C - conization", start date: 1959 (unspecified if ongoing); "vaginal delivery" (unspecified if ongoing), notes: Birth of six children 1960, 1961, 1963, 1969, 1970, 1972 with normal vaginal delivery; "Vein stripping, Left leg", start date: 1971 (unspecified if ongoing); "Cholecystectomy", start date: 1990 (unspecified if ongoing); "Hysterectomy", start date: 1993 (unspecified if ongoing); "Cataract removal, bilateral", start date: 2012 (unspecified if ongoing); "Emergency incarcerated umbilical hernia repair", start date: 2016 (unspecified if ongoing); "Insertion of pacemaker", start date: Jan2018 (unspecified if ongoing); "Pneumonia", start date: Oct2020 (unspecified if ongoing); "Congestive heart failure", start date: Oct2020 (unspecified if ongoing); "macular degeneration" (ongoing), notes: because of old age. Concomitant medication(s) included: LEVOTHYROXINE taken for thyroid disorder (ongoing); CARVEDILOL taken for blood pressure measurement (ongoing); LISINOPRIL taken for blood pressure measurement (ongoing); FUROSEMIDE (ongoing); POTASSIUM (ongoing); ISOSORBIDE MONONITRATE (ongoing); SIMVASTATIN taken for blood cholesterol (ongoing); ALPRAZOLAM (ongoing); ASPIRINE (ongoing); VITAMIN D [VITAMIN D NOS] (ongoing). Vaccination history included: Bnt162b2 (Dose 1, Site of injection: Arm, Route of administration: Intramuscular, Batch/Lot number: EN6201), administration date: 16Feb2021, when the patient was 85 years old, for Covid-19 immunization; Bnt162b2 (Dose 2, Site of injection: Arm, Route of administration: Intramuscular, Batch/Lot number: EN6206), administration date: 09Mar2021, when the patient was 85 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 16Oct2021, outcome "unknown", described as "Dose: 3rd; Date: 16Oct2021"; OFF LABEL USE (non-serious) with onset 16Oct2021, outcome "unknown", described as "off label use"; HAIR DISORDER (non-serious), outcome "unknown", described as "Caller's hair gradually become more and more curly, "hair changing" after the vaccination.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of hair disorder.  Additional information: Patient had no Specific relevant test for thromboembolic events with thrombocytopenia.  Follow-up attempts are completed, and no further information expected.